Drug design for neuropathic pain regulation from traditional Chinese medicine

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Tou, Weng Ieong ^a   Chang, Su Sen ^b   Lee, Cheng Chun ^a,b   Chen, Calvin Yu Chian ^b,c,d,e  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY BEIGANG HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BENZODIOXOLE DERIVATIVE; ALKENE; AMIDE; FABP1 PROTEIN, HUMAN; FATTY ACID BINDING PROTEIN; FUSED HETEROCYCLIC RINGS; GUINEENSINE; RETROFRACTAMIDE A;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BINDING SITE; CHEMISTRY; CHINESE MEDICINE; DRUG ANTAGONISM; DRUG DESIGN; HUMAN; METABOLISM; MOLECULAR DOCKING; MOLECULAR GENETICS; NEURALGIA; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RAT; SEQUENCE ALIGNMENT; STATISTICAL MODEL; SUPPORT VECTOR MACHINE;

ALKENES; AMIDES; AMINO ACID SEQUENCE; ANIMALS; BENZODIOXOLES; BINDING SITES; DRUG DESIGN; FATTY ACID-BINDING PROTEINS; HETEROCYCLIC COMPOUNDS, 2-RING; HUMANS; LINEAR MODELS; MEDICINE, CHINESE TRADITIONAL; MOLECULAR DOCKING SIMULATION; MOLECULAR SEQUENCE DATA; NEURALGIA; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RATS; SEQUENCE ALIGNMENT; SUPPORT VECTOR MACHINES;

MLCS; MLOWN;

EID: 84880533871     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00844     Document Type: Article

References (40)

1. Jensen, T. S. et al. A new definition of neuropathic pain. Pain 152, 2204-2205 (2011).
2. Turk, D. C., Audette, J., Levy, R. M., Mackey, S. C. & Stanos, S. Assessment and treatment of psychosocial comorbidities in patients with neuropathic pain. Mayo Clin Proc 85, S42-50 (2010).
3. Baron, R., Tolle, T. R., Gockel, U., Brosz, M. & Freynhagen, R. A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: Differences in demographic data and sensory symptoms. Pain 146, 34-40 (2009).
4. Mahn, F. et al. Sensory symptom profiles and co-morbidities in painful radiculopathy. PLoS One 6, e18018 (2011).
5. Liu, J. et al. Multiple pathways involved in the biosynthesis of anandamide. Neuropharmacology 54, 1-7 (2008).
6. Fride, E. Endocannabinoids in the central nervous system--an overview. Prostaglandins Leukot Essent Fatty Acids 66, 221-233 (2002).
7. Cravatt, B. F. et al. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci U S A 98, 9371-9376 (2001).
8. McKinney, M. K. & Cravatt, B. F. Structure and function of fatty acid amide hydrolase. Annu Rev Biochem 74, 411-432 (2005).
9. Hohmann, A. G. & Suplita, R. L. 2nd. Endocannabinoid mechanisms of pain modulation. Aaps J 8, E693-708 (2006).
10. Jhaveri, M. D., Richardson, D. & Chapman, V. Endocannabinoidmetabolism and uptake: novel targets for neuropathic and inflammatory pain. Br J Pharmacol 152, 624-632 (2007).
11. Lambert, D. M. Allergic contact dermatitis and the endocannabinoid system: from mechanisms to skin care. ChemMedChem 2, 1701-1702 (2007).
12. Bisogno, T. & Di Marzo, V. Short- and long-term plasticity of the endocannabinoid system in neuropsychiatric and neurological disorders. Pharmacol Res 56, 428-442 (2007).
13. Karsak, M. et al. Attenuation of allergic contact dermatitis through the endocannabinoid system. Science 316, 1494-1497 (2007).
14. Maione, S. et al. Analgesic actions ofN-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors. Br J Pharmacol 150, 766-781 (2007).
15. Jhaveri, M. D., Richardson, D., Kendall, D. A., Barrett, D. A. & Chapman, V. Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain. J Neurosci 26, 13318-13327 (2006).
16. Kathuria, S. et al. Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9, 76-81 (2003).
17. Bisogno, T. et al. Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase. Biochem Biophys Res Commun 248, 515-522 (1998).
18. Zhang, D. et al. Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets. Neuropharmacology 52, 1095-1105 (2007).
19. Fu, J. et al. A catalytically silent FAAH-1 variant drives anandamide transport in neurons. Nat Neurosci 15, 64-69 (2012).
20. Chen, C. Y. C. TCM Database@Taiwan: The World's largest traditional Chinese medicine database for drug screening in silico. PLoS One 6, e15939 (2011).
21. Mileni, M. et al. X-ray crystallographic analysis of alpha-ketoheterocycle inhibitors bound to a humanized variant of fatty acid amide hydrolase. J Med Chem 53, 230-240 (2010).
22. Lovell, S. C. et al. Structure validation by Calpha geometry: phi, psi and Cbeta deviation. Proteins 50, 437-450 (2003).
23. Brooks, B. R. et al. CHARMM: the biomolecular simulation program. J Comput Chem 30, 1545-1614 (2009).
24. Discovery Studio v. 2.5.5 (San Diego, CA).
25. Sit, S. Y. et al. Oxime carbamate--discovery of a series of novel FAAH inhibitors. Bioorg Med Chem Lett 20, 1272-1277 (2010).
26. Natick, M., US. MATrix LABoratory. The MathWorks Inc.
27. Hasegawa, K. & Funatsu, K. Non-Linear Modeling and Chemical Interpretation with Aid of Support Vector Machine and Regression. Curr Comput-Aid Drug 6, 24-36 (2010).
28. Kim, J. H., Lee, J., Oh, B., Kimm, K. & Koh, I. S. Prediction of phosphorylation sites using SVMs. Bioinformatics 20, 3179-3184 (2004).
29. Wieland, R. et al. A new library to combine artificial neural networks and support vector machines with statistics and a database engine for application in environmental modeling. Environ Modell Softw 25, 412-420 (2010).
30. St Louis, M. USA: Tripos. SYBYL-X. 1.1.
31. Stanton, D. T. QSAR and QSPR Model Interpretation Using Partial Least Squares (PLS) Analysis. Curr Comput-Aid Drug 8, 107-127 (2012).
32. Zoete, V., Cuendet, M.A., Grosdidier, A. & Michielin, O. SwissParam, a Fast Force Field Generation Tool For Small Organic Molecules. J Comput Chem 32, 2359-2368 (2011).
33. Hess, B., Kutzner, C., van der Spoel, D. & Lindahl, E.GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput 4, 435-447 (2008).
34. Priyakumar, U. D. & MacKerell, A. D. Comparison of the CHARMM27, AMBER4.1 and BMS nucleic acid force fields via free energy calculations of base flipping. Abstr Pap Am Chem S 230, U1391-U1392 (2005).
35. Darden, T. A. & Pedersen, L. G. Molecular modeling: an experimental tool. Environ Health Perspect 101, 410-412 (1993).
36. Kabsch, W. & Sander, C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22, 2577-2637 (1983).
37. Lee, S. A. et al.Methylpiperate derivatives from Piper longum and their inhibition of monoamine oxidase. Arch Pharm Res 31, 679-683 (2008).
38. Rho, M. C. et al. ACAT inhibition of alkamides identified in the fruits of Piper nigrum. Phytochemistry 68, 899-903 (2007).
39. Zhang, H., Matsuda, H., Nakamura, S. & Yoshikawa, M. Effects of amide constituents from pepper on adipogenesis in 3T3-L1 cells. Bioorg Med Chem Lett 18, 3272-3277 (2008).
40. Lin, Z., Liao, Y., Venkatasamy, R., Hider, R. C. & Soumyanath, A. Amides from Piper nigrum L. with dissimilar effects on melanocyte proliferation in-vitro. J Pharm Pharmacol 59, 529-536 (2007).